Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot study.
bioRxiv : the preprint server for biology April 11, 2023 Shinnyi Chou, Kenneth N Fish, David A Lewis et al. preprint
Individuals with schizophrenia are at elevated genetic risks for comorbid cannabis use, and often experience exacerbations of cognitive and psychotic symptoms when exposed to cannabis. These findings have led a number of investigators to examine cannabinoid CB1 receptor (CB1R) alterations in schizophrenia, though with conflicting results. We recently demonstrated the presence of CB1R in both...